Similar Items: Reduced CB1 Cannabinoid Receptor Expression in Alzheimer's Disease and Transgenic Mouse Models
- Associations between neuronavigated rTMS‐mediated functional connectome plasticity and neurotransmitter receptors in Alzheimer's disease
- Alzheimer's disease drug development pipeline: 2026
- Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
- Interchangeability of CSF and PET to identify Alzheimer's disease pathology
- The multifaceted roles of the transcription factor SP1 in the pathogenesis of Alzheimer's disease: From molecular regulation to therapeutic targets
- Association of SPHK1 polymorphisms with Alzheimer's disease susceptibility: Functional impact of the rs2247856 SNP on transcriptional efficiency